Skip to main
KMB

Kimberly-Clark (KMB) Stock Forecast & Price Target

Kimberly-Clark (KMB) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 8%
Buy 17%
Hold 67%
Sell 0%
Strong Sell 8%

Bulls say

Kimberly-Clark is a leading manufacturer in the tissue and hygiene market, with over half of its sales derived from personal care and a significant portion from consumer tissue products. The company plans to enhance its market presence by integrating Kenvue's consumer health portfolio by the second half of 2026, further strengthening its diverse product offerings that include well-known brands such as Huggies and Kleenex. With a focus on ramping up innovation and an anticipated robust innovation pipeline for 2026, Kimberly-Clark is well-positioned to leverage new technology and enhance its competitive advantage in the industry.

Bears say

Kimberly-Clark has projected a -4.0% decline in organic sales for the third quarter of 2025, a significant reversal from prior expectations of +4.5%. Alongside this, the company's U.S. measured retail sales have also faced a decline of -2.7% for the same period, indicating ongoing challenges in its key market. Furthermore, earnings per share estimates have been revised downward, with forecasts for fiscal 2025 lowered from $7.60 to $7.41 and for 2026 from $8.00 to $7.85, reflecting deteriorating financial performance expectations.

Kimberly-Clark (KMB) has been analyzed by 12 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 17% recommend Buy, 67% suggest Holding, 0% advise Selling, and 8% predict a Strong Sell.

This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Kimberly-Clark (KMB) Forecast

Analysts have given Kimberly-Clark (KMB) a Hold based on their latest research and market trends.

According to 12 analysts, Kimberly-Clark (KMB) has a Hold consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $124.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $124.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Kimberly-Clark (KMB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.